You are searching for: hsa04929

---

T99149 Target Info	Target Name	HUMAN ERK activator kinase 2 (MEK2)
	Target type	. Target
	Disease	Metastatic melanoma; Neurofibromatosis type 1;
	Drugs	Trametinib	Drug Info

T18950 Target Info	Target Name	Leutinizing-hormone-releasing hormone (GNRH1)
	Target type	Successful Target
	Disease	Breast cancer; Solid tumour/cancer;
	Drugs	Leuprolide	Drug Info

T65236 Target Info	Target Name	G-protein coupled estrogen receptor 1 (GPER1)
	Target type	Successful Target
	Disease	Contraception; Lymphoma;
	Drugs	Segesterone acetate; ethinyl estradiol	Drug Info

T35940 Target Info	Target Name	ERK activator kinase 1 (MEK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T67619 Target Info	Target Name	RAC-alpha serine/threonine-protein kinase (AKT1)
	Target type	Successful Target
	Disease	Triple negative breast cancer; Colorectal cancer;
	Drugs	Capivasertib	Drug Info

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T71266 Target Info	Target Name	RAC-gamma serine/threonine-protein kinase (AKT3)
	Target type	Successful Target
	Disease	Breast cancer; Triple negative breast cancer;
	Drugs	Capivasertib	Drug Info

T78692 Target Info	Target Name	Inward rectifier potassium channel Kir3.4 (KCNJ5)
	Target type	Clinical trial Target
	Disease	Acute myeloid leukaemia; Hodgkin lymphoma;
	Drugs	phorbol 12-myristate 13-acetate	Drug Info

T05031 Target Info	Target Name	PI3-kinase beta (PIK3CB)
	Target type	Clinical trial Target
	Disease	Breast cancer; Squamous head and neck cell carcinom;
	Drugs	Buparlisib	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.